Tiny DNA modification has big impact on deadly tumors

November 2, 2018 by Bill Hathaway, Yale University
Credit: stock.adobe.com

A simple modification of a DNA base in small areas of the genome may explain why glioblastoma tumors are so deadly, researchers at Yale and the University of California-San Diego report Nov. 1 in the journal Cell.

Glioblastomas are particularly virulent tumors, with survival rates of only about three to six months. A major culprit is the existence of a group of special tumor cells that are highly resistant to standard therapies. The modification of the A base in DNA, one of four genetic letters which form the structural backbone of DNA, was found in large numbers in tumors, especially stem , researchers report. They also found the modification affects growth of human gliomas engrafted into mice brains.

This base modification was seen in earliest stage in embryo development and appears crucial to development of the fetus, but disappears later in adult life, the researchers note.

"But in the case of glioblastomas, cancer appears to hijack this mechanism," said Andrew Xiao, associate professor of genetics at the Yale Stem Cell Center, researcher with the Yale Cancer Center and co-corresponding author of the paper along with Jeremy Rich at Moores Cancer Center at UC-San Diego Health.

The several-hundredfold increase of modified A base in tumors—barely detectable in normal brain tissues—means the base may make an attractive target for new drug therapies, Xiao said.

The modification may also be found in other tumors as well and may suggest new ways to treat now-incurable brain tumors, he said.

Explore further: A breakthrough for understanding glioblastoma—origin cells for deadly brain tumors identified

More information: Qi Xie et al. N-methyladenine DNA Modification in Glioblastoma, Cell (2018). DOI: 10.1016/j.cell.2018.10.006

Related Stories

A breakthrough for understanding glioblastoma—origin cells for deadly brain tumors identified

August 2, 2018
A new study by KAIST researchers identified where the mutation causing glioblastoma starts. According to the study, neural stem cells away from the tumor mass are the cells of origin that contain mutation drivers for glioblastoma, ...

Scientists target glioma cancer stem cells, which could improve patient survival

February 5, 2018
Glioblastoma multiforme is the most common and aggressive primary brain tumor and has one of the worst survival rates of all cancers. Despite surgery, radiation and chemotherapy, these tumors virtually always become resistant ...

Vulnerability identified for subtypes of glioblastoma

November 30, 2017
Glioblastoma, the most common and aggressive form of brain cancer, typically fails to respond to treatment or rapidly becomes drug resistant. In a paper published online in the journal Cancer Cell on November 30, University ...

Researchers reveal weakness in defenses of deadly brain tumor

August 13, 2014
Glioblastoma is a complex, deadly, and hard-to-treat brain cancer, but Yale School of Medicine researchers may have found the tumor's Achilles heel.

Researchers find a pathway that leads to resistance of aggressive brain tumor treatment

February 16, 2018
Glioblastoma multiforme is one of the most common and deadly brain tumors. Despite the initial responsiveness to state-of-the-art therapies, tumors virtually always become resistant and eventually recur. Researchers at Dartmouth's ...

Recommended for you

A study suggests that epigenetic treatments could trigger the development of aggressive tumours

November 20, 2018
A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and published in the journal Nature Cell Biology examined whether the opening of chromatin (a complex formed by DNA bound to proteins) is the factor ...

'Druggable' cancer target found in pathway regulating organ size

November 20, 2018
It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer. It's further known that a major player in this pathway, ...

Redefining colorectal cancer subtypes

November 20, 2018
There is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each year, can be categorized into distinct molecular subtypes. In a paper published recently in the journal Genome ...

Proposed cancer treatment may boost lung cancer stem cells, study warns

November 20, 2018
Epigenetic therapies—targeting enzymes that alter what genes are turned on or off in a cell—are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston ...

Aspirin and omega-3 reduce pre-cancerous bowel polyps

November 19, 2018
Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

Scientists trained a computer to classify breast cancer tumors

November 19, 2018
Using technology similar to the type that powers facial and speech recognition on a smartphone, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have trained a computer to analyze breast ...


Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (3) Nov 02, 2018
This only shows that random genetic mutations lead to corruption and death, not evolution.
5 / 5 (1) Nov 02, 2018
Ahh, beggingforanending. Not sure which cult of sockpuppets you are fronting for? But never mind, as it is obvious you are barely functionally literate. The typical product of a church school. Yet another fail by primitive anthropophagic stuporstition.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.